ubiquitin
ub
ubiquitinlik
modifi
interferon
stimul
gene
particip
host
defens
viral
infect
virus
includ
sever
acut
respiratori
syndrom
human
coronaviru
sar
hcov
coopt
pathway
advantag
evolv
effector
protein
counter
proinflammatori
properti
host
protein
compar
substrat
specif
papainlik
proteas
plpro
recent
emerg
middl
eastern
respiratori
syndrom
mer
hcov
relat
proteas
sar
sar
plpro
biochem
assay
show
similar
sar
plpro
mer
plpro
deubiquitin
deisgyl
enzym
analysi
intrins
deubiquitin
enzym
dub
activ
viral
proteas
reveal
uniqu
differ
recognit
cleavag
specif
polyub
chain
first
mer
plpro
show
broad
linkag
specif
cleavag
polyub
chain
sar
plpro
prefer
cleav
polyub
chain
second
mer
plpro
cleav
polyub
chain
monodistribut
manner
one
ub
time
sar
plpro
prefer
cleav
polyub
chain
sens
diub
moieti
minim
recognit
element
use
didistribut
cleavag
mechan
didistribut
cleavag
mechan
sar
plpro
appear
uncommon
among
uspfamili
dub
relat
usp
famili
member
human
display
mechan
propos
intrins
enzymat
differ
sar
mer
plpro
help
identifi
proinflammatori
substrat
viral
dub
guid
design
therapeut
combat
infect
coronavirus
emerg
novel
infecti
agent
zoonot
origin
cross
speci
barrier
pose
signific
risk
human
health
constant
threat
today
decad
ago
novel
coronaviru
caus
sever
upper
respiratori
infect
human
term
sever
acut
respiratori
syndrom
human
coronaviru
sar
hcov
sar
caus
global
pandem
mortal
rate
due
high
infect
rate
eventu
contain
health
care
profession
earli
detect
patient
isol
howev
date
specif
treatment
avail
sar
type
coronaviru
infect
either
form
small
molecul
inhibitor
vaccin
although
last
known
humantohuman
sar
infect
chain
broken
center
diseas
control
prevent
cdc
recent
classifi
sar
select
agent
pose
high
risk
human
health
owe
high
risk
reemerg
lack
avail
treatment
option
sar
began
fade
public
memori
new
human
coronaviru
emerg
term
middl
eastern
respiratori
syndrom
mer
hcov
date
infect
close
thousand
individu
mortal
rate
http
wwwcdcgovcoronavirusmersindexhtml
mer
hcov
like
sar
hcov
beta
coronaviru
zoonot
origin
also
relat
coronavirus
found
bat
recent
evid
suggest
mer
hcov
like
util
dromedari
camel
intermediari
host
mer
hcov
like
sar
hcov
caus
sever
respiratori
infect
well
acut
renal
failur
case
mer
current
ongo
pandem
first
us
case
report
may
ubiquitin
small
protein
posttransl
modifi
target
substrat
defin
enzymat
cascad
involv
enzym
convers
deubiquitin
enzym
dub
cleav
ubiquitin
substrat
ubiquitin
conjug
via
seven
lysin
well
via
nterminu
lead
differ
function
consequ
modifi
substrat
common
function
ubiquitin
proteasom
degrad
substrat
mediat
polyubiquitin
polyub
chain
ubiquitinlik
ubl
modifi
compos
two
ubiquitinlik
fold
tandem
conjug
substrat
orthogon
enzymat
cascad
play
role
tag
newli
synthes
protein
antivir
respons
topolog
resembl
open
conform
linear
diub
molecul
chain
dynam
contextdepend
topolog
depend
interact
protein
protein
counter
proinflammatori
properti
ublconjug
host
protein
coronavirus
one
mechan
reli
dampen
host
immun
respons
via
action
viral
isopeptidas
thu
sar
highli
promis
drug
target
one
two
viral
process
proteas
sar
papainlik
process
proteas
plpro
multifunct
papainlik
cystein
proteas
addit
cleav
viral
polypeptid
defin
posit
sar
plpro
remov
ubiquitin
cellular
conjug
activ
believ
import
antiinflammatori
function
although
specif
ubiquitinandor
substrat
yet
identifi
recent
equival
process
proteas
mer
hcov
term
mer
plpro
also
shown
deubiquitin
activ
express
cell
present
biochem
character
mer
plpro
comparison
isopeptidas
activ
sar
plpro
show
similar
sar
plpro
purifi
recombin
mer
plpro
dualfunct
isopeptidas
cleav
ubiquitin
conjug
use
positionalscan
substrat
librari
screen
show
mer
plpro
broad
cleavag
site
specif
term
amino
acid
sequenc
featur
share
sar
plpro
furthermor
demonstr
mer
plpro
monodistribut
dub
recogn
cleav
one
ubiquitin
unit
within
chain
also
demonstr
mer
plpro
broad
specif
dub
respect
ubub
linkag
contrast
mer
plpro
found
unit
recognit
cleavag
sar
plpro
diubiquitin
unit
within
chain
length
three
greater
make
uniqu
didistribut
dub
find
allow
us
dispel
recent
notion
sar
plpro
prefer
cleav
conjug
oppos
ubiquitin
conjug
sar
plpro
possess
capac
effici
cleav
polyub
chain
similar
rate
furthermor
show
uniqu
didistribut
mechan
sar
plpro
result
accumul
unit
well
monoub
conjug
substrat
could
function
consequ
coronaviru
infect
studi
reveal
key
mechanist
differ
two
relat
coronaviru
proteas
may
use
identifi
cellular
substrat
may
aid
inhibitor
design
strategi
final
studi
reinforc
need
investig
compar
advantag
deubiquitin
versu
deisgyl
might
confer
coronavirus
unless
otherwis
indic
dub
incub
excess
activitybas
probe
ubpa
monoubvm
indic
time
min
hr
mm
tri
mm
nacl
mm
dtt
reaction
termin
load
sampl
buffer
ld
invitrogen
boil
min
analyz
sdspage
syprostain
gel
imag
biorad
geldoc
imag
unless
otherwis
indic
reaction
volum
ubiquitin
chain
mm
tri
mm
nacl
mm
dtt
cleav
nm
dub
indic
time
timecours
assay
serial
dilut
dub
start
hr
reaction
termin
load
sampl
buffer
ld
invitrogen
boil
min
analyz
sdspage
syprostain
gel
imag
biorad
geldoc
imag
quantifi
use
imagej
crop
indic
determin
appar
k
cat
k
sar
mer
plpro
ubiquitinamc
aminomethylcoumarin
prepar
serial
dilut
start
respect
mm
tri
mm
nacl
mm
dtt
sar
plpro
use
nm
mer
plpro
use
nm
final
reaction
volum
substrat
dub
preincub
min
cleavag
ublamc
perform
use
spectramax
fluoresc
plate
reader
run
softmax
pro
softwar
molecular
devic
oper
kinet
mode
black
flatbottom
plate
corn
free
amc
fluoresc
monitor
excit
nm
emiss
nm
initi
linear
cleavag
rate
v
fit
michealismenten
equat
use
prism
softwar
graphpad
base
free
amc
standard
curv
indic
experi
perform
duplic
error
bar
indic
sem
synthesi
psscl
screen
subsit
carri
describ
previous
complet
synthesi
analysi
step
sublibrari
dissolv
biochem
grade
dmso
concentr
mm
store
use
synthesi
individu
fluorogen
substrat
carri
use
classic
solid
phase
peptid
synthesi
method
describ
previous
substrat
purifi
hplc
water
solvent
deliveri
modul
water
detector
system
use
semiprepar
water
spherisorb
column
solvent
composit
follow
phase
tfa
phase
b
tfa
puriti
substrat
confirm
analyt
hplc
use
water
spherisorb
column
final
molecular
weight
substrat
confirm
mass
spectrometri
analysi
compound
least
pure
individu
substrat
dissolv
mm
dmso
store
use
mer
plpro
assay
enzym
preincub
min
buffer
follow
addit
corn
plate
well
contain
substrat
reaction
monitor
min
kinet
mode
calcul
initi
veloc
v
linear
portion
obtain
progress
curv
use
result
present
averag
least
three
experi
analysi
result
base
total
rel
fluoresc
unit
rfu
everi
sublibrari
set
highest
valu
adjust
result
accordingli
individu
substrat
screen
mer
plpro
buffer
contain
mm
nacl
mm
dtt
mm
tri
hofmeist
salt
sodium
citrat
enzym
preincub
min
ad
well
contain
substrat
assay
condit
follow
reaction
volum
final
substrat
concentr
rang
mer
plpro
concentr
concentr
dmso
assay
less
vv
releas
acc
fluorophor
monitor
continu
excit
nm
emiss
nm
initi
veloc
rate
fit
use
graphpad
prism
michealismenten
curv
determin
v
max
k
lysat
human
interferon
beta
treat
hela
cell
total
protein
per
reaction
incub
serial
dilut
dub
reaction
volum
hr
presenc
mm
dtt
dub
time
cours
assay
reaction
termin
boil
sd
load
buffer
result
analyz
sdspage
western
blot
blot
develop
chemiluminesc
character
mer
plpro
clone
express
put
mer
plpro
includ
ubiquitinlik
ubl
domain
use
domain
limit
base
align
relat
sar
plpro
supplementari
fig
first
test
mer
plpro
compar
activ
fluorogen
model
substrat
ubiquitinand
unlik
sar
plpro
display
strong
prefer
cleav
ubiquitinamc
fig
supplementari
fig
c
ref
mer
plpro
display
signific
prefer
either
process
ubiquitinamc
similarli
determin
overal
rel
k
cat
k
valu
fig
addit
mer
plpro
reactiv
sar
plpro
toward
ubiquitin
activ
base
probe
ubpa
use
coval
label
activ
dub
fig
inlet
overal
suggest
diverg
prefer
sar
mer
plpro
toward
ub
model
substrat
next
determin
cleavag
site
specif
mer
plpro
regard
primari
amino
acid
sequenc
cleavag
site
residu
substrat
correspond
ubiquitin
gener
posit
scan
substrat
combinatori
librari
psscl
supplementari
fig
previous
use
assay
specif
sar
plpro
dub
result
psscl
screen
demonstr
mer
plpro
absolut
requir
gli
posit
accommod
wide
varieti
hydrophob
amino
acid
posit
fig
context
tetrapeptid
screen
prefer
amino
acid
leu
follow
arg
ly
hydrophob
residu
prefer
amino
acid
also
leu
follow
mostli
hydrophob
residu
librari
screen
result
line
three
cleavag
site
mer
plpro
process
within
viral
polypeptid
fig
site
gli
residu
ile
ly
val
either
leu
ile
thu
result
indic
activ
site
mer
plpro
appear
less
stringent
compar
psscl
librari
screen
result
dub
uspfamili
contain
sar
mer
plpro
appear
mer
plpro
exhibit
lesser
degre
specif
either
sar
plpro
usp
specif
broad
yet
stringent
sar
plpro
supplementari
fig
notabl
date
isopeptidas
shown
accommod
pro
posit
librari
screen
suggest
mer
plpro
may
abl
cleav
substrat
contain
pro
posit
fig
bottom
panel
confirm
cleavag
pro
gener
uniqu
tetrapeptid
defin
sequenc
determin
rate
cleavag
mer
plpro
fig
result
show
pro
accommod
tetrapeptid
test
although
reduc
rate
littl
discrimin
leu
arg
posit
recent
studi
gener
ubiquitin
mutant
resist
cleavag
differ
famili
human
dub
conjug
substrat
polyub
chain
intrigu
abil
mer
plpro
accommod
pro
correspond
test
whether
mer
plpro
cleav
inde
show
context
diubiquitin
diub
chain
mer
plpro
sar
plpro
cd
could
cleav
chain
although
weakli
compar
wildtyp
chain
fig
abil
mer
plpro
cleav
observ
diub
chain
linear
diub
chain
suggest
level
linkag
specif
display
mer
plpro
process
ubiquitin
chain
thu
determin
linkag
specif
mer
plpro
assay
panel
diub
molecul
eight
linkag
timecours
assay
use
differ
concentr
mer
plpro
demonstr
mer
plpro
broadspecif
dub
display
cleavag
linear
diub
chain
fig
top
panel
supplementari
figur
contrast
cleavag
diub
chain
sar
plpro
display
broad
linkag
specif
assay
robust
cleavag
mer
plpro
compar
two
enzym
similar
enzym
concentr
fig
bottom
panel
neither
dub
abl
cleav
linear
diub
diub
although
latter
could
structur
quit
compact
low
activ
sar
plpro
diub
chain
compel
us
test
activ
longer
ubiquitin
chain
surprisingli
analyz
chain
mer
sar
plpro
abl
cleav
mutant
ubiquitin
chain
fig
right
panel
cleavag
chain
impair
compar
wildtyp
chain
howev
slow
kinet
allow
visual
differ
cleavag
intermedi
mer
sar
plpro
compar
fig
left
right
panel
tetraub
cleavag
pattern
cd
mer
plpro
appear
resembl
distribut
cleavag
pattern
oppos
sar
plpro
cleavag
pattern
accumul
diub
intermedi
form
prior
appear
monoub
product
cleavag
suggest
sar
mer
plpro
recogn
ubiquitin
chain
differ
manner
interestingli
detail
look
activ
site
cleft
crystal
structur
cd
sar
mer
plpro
bound
monoubiquitin
suggest
lack
defin
pocket
mer
plpro
sar
plpro
pocket
present
cd
supplementari
fig
potenti
explain
abil
viral
dub
accommod
pro
thu
overal
mer
plpro
dualspecif
isopeptidas
cleav
variou
ubiquitin
conjug
similar
rate
contrast
sar
plpro
appear
poorer
dub
diub
substrat
superior
deisgylas
compar
mer
plpro
importantli
cleavag
wildtyp
tetraub
chain
reveal
sar
plpro
cleav
tetraub
chain
effici
mer
plpro
wherea
opposit
true
cleavag
diub
chain
differ
suggest
mer
sar
plpro
mechanist
distinct
abil
recogn
ubiquitin
conjug
investig
uniqu
properti
sar
plpro
stabil
diub
cleavag
product
polyub
chain
compar
process
rate
sar
mer
plpro
tetra
triand
diub
substrat
fig
show
sar
plpro
fig
top
panel
fig
black
line
exhibit
neglig
cleavag
diub
chain
readili
process
tetraand
triub
chain
cleavageintermedi
pattern
timecours
studi
indic
sar
plpro
cleav
triub
chain
diub
monoub
product
cleavag
tetraub
chain
sar
plpro
complex
either
gener
triub
monoub
product
process
diub
monoub
tetraub
cleav
gener
two
diub
unit
thu
differ
mode
tetraub
cleavag
result
accumul
diub
monoub
along
transient
appear
triub
form
fig
sar
plpro
therefor
appear
preferenti
recogn
cleav
chain
didistribut
manner
didistribut
cleavag
mechan
best
demonstr
analyz
cleavag
pentaub
chain
lower
temperatur
fig
allow
visual
immedi
cleavag
intermedi
visual
strike
initi
cleavag
product
aris
highli
compar
rate
process
pentaub
chain
triand
diub
intermedi
result
strongli
indic
cleavag
fivememb
ubiquitin
chain
take
place
stochast
either
nd
rd
ubiquitin
moieti
rd
th
ubiquitin
moieti
either
end
chain
result
transient
accumul
triand
diub
cleavag
intermedi
lack
transient
accumul
singl
cleavag
intermedi
combin
observ
monoand
tetraub
cleavag
intermedi
suggest
lack
direction
ubiquitin
chain
cleavag
strongli
suggest
sar
plpro
distribut
dub
process
ubiquitin
chain
unit
two
consequ
cleavag
diub
molecul
monom
appear
inhibit
unlik
sar
plpro
cleavag
rate
mer
plpro
fig
bottom
panel
fig
grey
line
nearli
ident
ubiquitin
chain
variou
length
pattern
cleavag
intermedi
demonstr
mer
plpro
mono
distribut
dub
cleav
singl
unit
ubiquitin
like
major
dub
studi
thu
far
diub
stabil
cleavag
pattern
sar
plpro
appear
diub
intermedi
accumul
cleavag
tetraub
chain
fig
addit
chain
cleav
poorli
sar
plpro
compar
mer
plpro
supplementari
fig
sar
mer
plpro
fail
cleav
linear
tetraub
chain
even
equimolar
dub
substrat
concentr
supplementari
fig
result
collect
support
idea
mer
plpro
broadspecif
monodistribut
dub
sar
plpro
didistribut
significantli
activ
longer
ubiquitin
chain
compar
poor
cleavag
activ
sar
plpro
diub
chain
could
due
inabl
sar
plpro
recogn
bind
diub
chain
test
gener
recombin
histag
catalyt
mutant
dub
use
pulldown
assay
incub
differ
mixtur
ubl
unit
fig
show
sar
plpro
preferenti
bind
diub
chain
monoub
present
equimolar
ratio
contrast
cd
preferenti
favor
monoub
diub
mer
plpro
bound
similarli
fig
interestingli
sar
plpro
slightli
favor
diub
chain
present
wherea
opposit
true
mer
plpro
fig
thu
inabl
sar
plpro
recogn
diub
order
cleav
perhap
bind
diub
sar
plpro
mediat
region
render
ubub
intern
cleavag
site
inaccess
cleavag
activ
site
proteas
recent
advanc
chemic
biolog
enabl
gener
ubiquitin
activitybas
probe
abp
dub
linkagespecif
warhead
use
coval
label
activ
site
cy
dub
posit
two
ubiquitin
moieti
diub
probe
use
tool
test
whether
sar
could
effici
bind
diub
across
activ
site
posit
adapt
nomenclatur
amino
acid
posit
proteas
cleavag
site
posit
occupi
ubiquitinlik
protein
domain
order
favor
label
abp
whether
anoth
posit
util
would
prevent
reactiv
see
model
fig
also
sar
mer
plpro
contain
ubiquitinlik
ubl
domain
nterminu
wonder
ubl
domain
play
role
correct
posit
longer
ubiquitin
chain
sar
plpro
show
diub
abp
well
monoubabp
effici
label
mer
plpro
mutant
form
coval
modifi
dub
fig
right
side
fail
effici
label
sar
plpro
mutant
fig
left
side
thu
lack
label
sar
plpro
like
due
select
bind
chain
posit
posit
therefor
activ
site
cy
react
warhead
abp
consist
ubabp
label
remov
ubldomain
either
sar
mer
plpro
effect
cleavag
rate
pattern
intermedi
observ
supplementari
fig
thu
ubl
domain
mer
sar
plpro
dispens
ubiquitin
chain
recognit
process
activ
determin
whether
differ
mechan
substrat
recognit
process
mer
sar
plpro
remain
observ
context
multipl
cellular
substrat
aim
creat
experiment
system
would
contain
isgyl
polyubiquitin
substrat
could
simultan
monitor
appear
cleavag
intermedi
ubiquitinlik
protein
end
treat
hela
cell
interferonbeta
proteasom
inhibitor
induc
stabil
isgyl
polyubiquitin
substrat
cell
next
lysat
incub
recombin
viral
dub
timecours
assay
substrat
process
pattern
analyz
western
blot
probe
total
cellular
ubiquitin
conjug
fig
result
indic
mer
sar
plpro
potent
deisgyl
enzym
sar
plpro
appear
process
higher
molecular
weight
hmw
ubiquitin
conjug
slightli
effici
importantli
context
mixtur
cellular
substrat
sar
plpro
initi
accumul
diub
chain
cleavag
product
mer
plpro
fig
black
box
assay
cell
lysat
serial
dilut
viral
dub
supplementari
fig
f
also
indic
initi
stabil
diub
product
sar
plpro
overal
demonstr
mechanist
differ
sar
mer
plpro
respect
ubiquitin
chain
process
context
cellular
substrat
summari
demonstr
sar
plpro
preferenti
recogn
unit
possibl
pocket
effici
cleav
next
ubiquitin
chain
result
accumul
product
result
strongli
suggest
minim
prefer
substrat
sar
plpro
chain
span
see
model
fig
importantli
relat
mer
plpro
lack
uniqu
recognit
cleavag
prefer
recognit
diub
moieti
cleavag
third
ubiquitin
triub
chain
sar
plpro
presum
via
subsit
distal
posit
see
model
figur
top
shown
black
solid
line
larg
base
presum
similar
recognit
two
ubiquitinlik
domain
could
occupi
subsit
restrict
posit
ctermin
glycin
cleav
altern
recognit
triub
chain
may
occur
bind
mode
proxim
posit
see
model
figur
top
shown
grey
dot
line
recognit
diub
would
take
place
side
cleavag
site
result
present
thu
far
differenti
two
mode
orient
within
triub
chain
given
symmetri
system
ident
size
cleavag
intermedi
thu
sought
determin
orient
ub
chain
cleavag
mechan
sar
plpro
differenti
distal
ub
chain
process
versu
proxim
mechan
would
place
recognit
unit
oppos
side
sar
activ
site
determin
direction
cleavag
mechan
gener
purifi
histag
substrat
conjug
flagtag
ubiquitin
flagub
chain
see
fig
schemat
supplementari
fig
chose
model
substrat
whose
autoconjug
result
ubiquitin
chain
purifi
conjug
flagub
chain
cleav
sar
plpro
timecours
assay
conjug
variou
length
well
free
appear
initi
cleavag
product
fig
compar
lane
ultim
two
uniqu
product
speci
stabil
sar
plpro
monoubconjug
free
fig
lane
supplementari
fig
cleavag
polyubconjug
mer
plpro
hand
result
accumul
monoubconjug
case
mer
plpro
even
though
initi
cleavag
intermedi
similar
sar
plpro
variou
length
conjug
final
product
free
fulli
deconjug
fig
right
side
result
consist
previou
experi
illustr
mechanist
differ
sar
mer
plpro
sar
plpro
stabil
cleavag
product
aris
unanchor
ubiquitin
chain
mer
plpro
addit
result
strongli
support
mechan
recognit
ubiquitin
chain
sar
plpro
context
conjug
substrat
take
place
via
distal
approach
via
subsit
supplementari
fig
proxim
bind
mode
latter
case
final
accumul
cleavag
product
would
diubconjug
substrat
two
ubiquitin
moieti
conjug
substrat
would
occupi
subsit
observ
figur
supplementari
fig
furthermor
appear
initi
cleavag
product
variou
length
also
support
distribut
cleavag
mechan
discrimin
posit
sar
mer
plpro
cleav
ubiquitin
chain
interestingli
distal
didistribut
cleavag
mechan
chain
appear
uniqu
sar
plpro
two
human
dub
usp
famili
also
accumul
monoub
conjug
final
cleavag
product
complet
deconjug
substrat
fig
supplementari
fig
collect
result
strongli
suggest
distribut
cleavag
mechan
sar
plpro
diub
moieti
recogn
subsit
may
lead
accumul
monoubconjug
substrat
depend
posit
cleavag
event
respect
substrat
fig
show
although
viral
polyprotein
process
proteas
mer
sar
coronavirus
effici
deubiquitin
deisgyl
enzym
util
differ
mechan
substrat
recognit
process
mer
plpro
monodistribut
deubiquitin
enzym
sar
plpro
prefer
recognit
unit
thu
distribut
deubiquitin
enzym
see
fig
supplementari
fig
discuss
previous
mer
plpro
demonstr
cleav
uband
express
cell
provid
direct
vitro
evid
demonstr
mer
plpro
dualspecif
isopeptidas
process
ubiquitin
similarli
analysi
consist
recent
report
substrat
specif
mer
plpro
although
author
note
slightli
higher
process
rate
mer
plpro
also
demonstr
cleav
ubiquitin
chain
one
ubiquitin
time
addit
demonstr
mer
plpro
broadspecif
dub
like
human
dub
usp
famili
cleav
variou
ubiquitin
linkag
similar
effici
except
linear
chain
lack
specif
cleav
diub
chain
somewhat
share
sar
plpro
diub
molecul
occupi
subsit
howev
given
prefer
sar
plpro
recogn
unit
discuss
detail
physiolog
relev
broad
linkag
specif
sar
plpro
subsit
remain
determin
interest
note
linear
ub
chain
cleav
either
sar
mer
plpro
even
though
cleavag
linear
diub
proteolyt
cleavag
viral
polypeptid
process
site
proteas
cleav
peptid
bond
oppos
variou
isopeptidebond
linkag
ubub
dimer
furthermor
sinc
cleavag
ubiquitin
chain
similar
topolog
linear
ub
chain
well
toler
mer
plpro
would
expect
viral
dub
might
also
cleav
linear
ub
chain
interestingli
human
dub
usp
famili
also
toler
linear
ub
chain
even
though
less
specif
toward
isopeptid
linkag
one
reason
explan
peptid
bond
glymet
junction
linear
ub
conform
rigid
sar
mer
plpro
human
dub
accommod
isopeptid
bond
via
ly
sidechain
far
flexibl
conform
flexibl
isopeptidelinkag
could
also
help
explain
lack
linkag
specif
ubiquitinubiquitin
linkag
occupi
bind
site
suggest
could
minim
contact
substrat
prime
side
cleavag
site
subsit
ubiquitin
chain
sequenc
follow
viral
polypeptid
follow
cleavag
site
hand
linear
diub
flexibl
cterminu
distal
ubiquitin
end
gli
continu
immedi
initi
met
rigid
proxim
ubiquitin
potenti
lead
ubub
conform
suitabl
bind
pocket
viral
plpro
structur
work
viral
dub
complex
longer
ubiquitin
chain
viral
polyprotein
substrat
span
activ
site
need
shed
light
prime
side
specif
viral
dub
hand
address
issu
unprim
side
specif
viral
dub
use
posit
scan
substrat
combinatori
librari
psscl
show
unlik
human
dub
sar
mer
plpro
broad
cleavag
site
specif
term
amino
acid
prefer
sar
mer
plpro
appear
loos
defin
pocket
activ
site
cleft
even
though
avail
crystal
structur
sar
mer
plpro
complex
monoub
indic
intric
network
hydrogen
bond
stabil
cterminu
ubiquitin
activ
site
cleft
nevertheless
abl
accommod
hitherto
dubresist
mutat
ubiquitin
suggest
greater
flexibl
activ
site
cleft
human
dub
interestingli
accommod
pro
sar
plpro
observ
context
longer
tetraub
chain
substrat
suggest
recognit
process
polyub
chain
sar
plpro
via
uniqu
mechan
whether
differ
viral
plpro
activ
site
specifi
may
exploit
inhibitor
design
strategi
yet
address
furthermor
demonstr
mechanist
differ
sar
mer
plpro
recogn
process
polyubiquitin
chain
fig
supplementari
fig
mer
plpro
monodistribut
dub
cleav
ubiquitin
chain
one
ubiquitin
time
like
major
human
dub
sar
plpro
preferenti
didistribut
dub
recogn
diub
molecul
minim
recognit
unit
process
third
ubiquitin
polyub
chain
remov
diub
substrat
uniqu
recognit
possibl
mediat
extend
bind
surfac
sar
plpro
conserv
mer
plpro
tradit
accept
sar
plpro
primarili
deisgyl
enzym
mainli
base
prefer
ubamc
propos
inaccur
descript
activ
function
sar
plpro
show
cleavag
polyub
chain
minim
triub
diubconjug
substrat
highli
effici
compar
conjug
mer
plpro
share
mechan
possibl
recogn
site
cleav
next
ub
site
broadli
linkageindepend
manner
minim
contact
site
fig
supplementari
fig
manuscript
prepar
two
recent
paper
mesecar
baker
group
demonstr
similar
mechan
bival
ubl
recognit
sar
plpro
share
mer
plpro
model
mutat
analysi
author
identifi
region
sar
plpro
respons
recognit
subsit
conserv
mer
plpro
model
ratia
et
al
also
suggest
interact
via
classic
hydrophob
patch
ubiquitin
interact
remain
demonstr
experiment
futur
precis
mutat
subsit
guid
structur
work
diubbound
sar
plpro
complex
allow
discrimin
surfac
involv
ubiquitin
vs
recognit
ultim
pave
way
determin
rel
contribut
deubiquitin
versu
deisgyl
coronaviru
pathogenesi
studi
fulli
support
ratia
et
al
model
show
uniqu
didistribut
cleavag
mechan
sar
plpro
like
result
stabil
speci
also
monoubiquitin
conjug
substrat
accumul
remnant
follow
substrat
deconjug
sar
plpro
monoubconjug
substrat
stabil
remnant
ubiquitin
substrat
occupi
subsit
first
cleavag
event
sar
plpro
leav
poor
substrat
sar
plpro
recogn
subsequ
cleavag
event
also
show
relat
uspfamili
dub
mer
plpro
share
featur
sar
plpro
accumul
diub
unit
monoubconjug
substrat
cleavag
product
monodistribut
dub
although
possibl
vivo
sar
plpro
may
ultim
remov
ubiquitin
molecul
substrat
tempt
specul
transient
stabil
monoubconjug
substrat
could
function
consequ
coronaviru
infect
howev
exact
vivo
substrat
sar
mer
plpro
current
ill
defin
biolog
signific
mode
diub
recognit
remain
elucid
howev
exampl
human
dub
appear
function
similarli
machadojosephin
famili
cystein
proteas
dub
shown
poor
deubiquitin
enzym
overal
demonstr
edit
longer
chain
recogn
ubiquitin
chain
via
uim
domain
cleav
proxim
recogn
element
addit
recent
solv
crystal
structur
human
dub
otu
famili
complex
diub
substrat
reveal
extend
ub
bind
surfac
respons
triub
process
monoub
diub
unit
function
addit
ubiquitinrecogn
domain
dub
contribut
biolog
pathway
driven
uniqu
dub
yet
address
mer
sar
plpro
primarili
process
proteas
cleav
viral
polypeptid
defin
posit
releas
nonstructur
effector
protein
interestingli
posit
scan
librari
screen
sar
mer
plpro
herein
faith
recapitul
natur
sequenc
cleav
within
viral
polypeptid
although
cleavag
site
part
ubiquitinlik
domain
viral
polypeptid
whether
sar
mer
plpro
capabl
cleav
hydrophob
posit
charg
amino
acid
expos
loop
human
protein
point
potenti
addit
virulencerel
nonubl
substrat
human
cell
yet
determin
contribut
sar
plpro
infect
sar
hcov
contribut
mer
plpro
toward
mer
hcov
infect
well
establish
catalyt
activ
proteas
requir
viral
polypeptid
process
thu
viral
dub
target
intens
drug
develop
effort
attempt
inhibit
viral
propag
recent
promis
small
molecul
inhibitor
develop
sar
hcov
base
abil
inhibit
sar
plpro
howev
inhibit
mer
plpro
suggest
find
common
anticoronavir
drug
base
plpro
could
difficult
task
vivo
test
compound
also
hamper
safeti
concern
use
highli
pathogen
level
virus
thu
recent
develop
proxi
experiment
system
use
transgen
mice
harbor
engin
sindbi
viru
level
organ
express
sar
mer
plpro
extrem
import
step
viral
infect
viral
genom
translat
polypeptid
express
host
immun
respons
must
suppress
ensur
time
viral
particl
assembl
propag
infect
accept
deconjug
activ
membranebound
viral
plpro
play
role
promot
viral
replic
host
deconjug
ubiquitinconjug
protein
infect
cell
contribut
downregul
innat
immun
function
howev
ident
ubiquitinublconjug
substrat
whose
deconjug
viral
plpro
essenti
pathogen
remain
ill
defin
whether
cleav
ubiquitin
ubl
conjug
viral
protein
ie
spare
degrad
proteasom
remov
mark
newli
synthes
protein
receiv
cellular
substrat
ie
dampen
host
immun
respons
deconjug
signal
molecul
within
vicin
membran
environ
remain
unknown
studi
perform
use
overexpress
system
reli
model
proinflammatori
substrat
also
current
unknown
extent
deisgyl
andor
deubiquitin
activ
contribut
pathogenesi
thu
identifi
viral
plpro
mutant
differenti
ubiquitin
recognit
cleavag
consider
interest
interestingli
mutat
plpro
affect
global
ubldeconjug
viral
polypeptid
process
recent
describ
could
aid
develop
attenu
virus
coronaviru
vaccin
develop
would
also
interest
determin
whether
two
plpro
enzym
function
swap
two
virus
determin
whether
coronaviru
infect
mere
requir
activ
process
proteaseisopeptidas
substrat
specif
proteas
key
factor
revers
genet
system
coronavirus
place
use
uncov
function
sar
protein
viral
pathogenesi
togeth
rapid
develop
fulllength
mer
hcov
genom
bacteri
artifici
chromosom
system
may
possibl
answer
question
near
futur
refer
web
version
pubm
central
supplementari
materi
compar
process
proteas
two
human
coronavirus
sar
mer
hcov
respect
activ
substrat
specif
ubiquitinlik
signal
molecul
ubiquitin
uncov
uniqu
mode
polyubiquitin
recognit
sar
proteas
